[Development and fate of premature infants--then and now]

Insights

Advances in technology enable survival for premature infants with very low birth weight. Historical context reveals evolving survival rates and persistent challenges in reducing serious sequelae for these vulnerable infants.

Area of Science:

  • Neonatal care
  • Pediatric intensive care
  • Perinatal medicine

Context:

  • Modern technology improves survival rates for very low birth weight infants.
  • Historical analysis of neonatal intensive care programs is crucial for evaluating current effectiveness.
  • Early 20th-century work by A. Ylppö laid groundwork for low birth weight infant survival.

Purpose:

  • To provide historical perspective on the survival and outcomes of low birth weight infants.
  • To discuss the evolution of intensive care for premature infants.
  • To highlight the ongoing challenges in reducing morbidity in surviving premature infants.

Summary:

  • Survival rates for premature infants have improved due to technological advancements.
  • Post-WWII therapeutic innovations initially worsened outcomes, but improvements in the 1960s reduced serious sequelae.
  • While mortality has decreased, the rate of severe long-term health issues in surviving premature infants has remained stable for 15 years.

Impact:

  • Informs current discussions on the effectiveness and efficiency of neonatal intensive care.
  • Emphasizes the need for continued research and technological innovation to reduce long-term morbidity.
  • Provides a historical framework for understanding progress and persistent challenges in neonatal survival and outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...